Meridian Bioscience Inc
LSE:0K0K
Relative Value
There is not enough data to reliably calculate the relative value of 0K0K.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
0K0K Competitors Multiples
Meridian Bioscience Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
M
|
Meridian Bioscience Inc
LSE:0K0K
|
1.5B USD | 4.5 | 35 | 15.5 | 18.9 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
61.4B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.3T JPY | 10.1 | 37 | 26.7 | 32.1 | |
| CH |
|
Alcon AG
SIX:ALC
|
30B CHF | 3.8 | 37 | 15.3 | 29.7 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
110.7B DKK | 3.9 | 27.1 | 14.1 | 16.8 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD | 3.5 | 36.5 | 16.6 | 21.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 2.7 | 29.5 | 13.1 | 21.2 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.7B CNY | 9.4 | 25.9 | 23.4 | 23.4 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD | 1.2 | -19.6 | 19.5 | 92.1 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
4B CHF | 5.1 | 20.9 | 13.6 | 18.4 | |
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
4.9B USD | 3.2 | 40.5 | 18.5 | 30.8 |